Prostatic Neoplasms: all 6,484 studies
Page 48 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer PatientsActive, not recruitingNCT02303327Phase 3
- MRI-Targeted Focal Ablation of the Prostate in Men With Prostate CancerCompletedNCT02303054Not applicable
- Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate CancerActive, not recruitingNCT02302105Not applicable
- Comparing Hypofractionated Radiotherapy Boost to Conventionally FractionatedCompletedNCT02300389Not applicable
- [18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate CancerCompletedNCT02297386Phase 1
- Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate CancerActive, not recruitingNCT02296229Not applicable
- Quantitative Prostate Cancer Contrast-enhanced UltrasoundStatus unknownNCT02295449Not applicable
- Stellate Ganglion Block for Hot Flushes in Men Treated With ADTWithdrawnNCT02295163Not applicable
- Focal Prostate Radiofrequency AblationStatus unknownNCT02294903Not applicable
- A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate CancerCompletedNCT02293707Phase 2
- Prostate Biomarkers in Men Consuming Tomato ProductsCompletedNCT02292524Not applicable
- SmartTarget THERAPYStatus unknownNCT02290561Not applicable
- Prospective Evaluation of Focal Brachytherapy Using Cesium-131 For Patients With Low Risk Prostate CancerWithdrawnNCT02290366Not applicable
- Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate CancerCompletedNCT02288936Phase 2
- Pilot Study of SBRT and CDX-1127 in Prostate CancerTerminatedNCT02284971Phase 1
- Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II TrialStatus unknownNCT02283346Phase 2
- Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow CytometryCompletedNCT02282644Not applicable
- 68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate CancerStatus unknownNCT02282137Phase 2
- Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate CancerTerminatedNCT02279693Not applicable
- Redes III Patient Navigator Qol StudyCompletedNCT02275754Not applicable
- Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic AcidCompletedNCT02274623Phase 1
- The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side EffectsCompletedNCT02274350
- Medical and Economic Evaluation for Intermediate-risk Prostate CancerStatus unknownNCT02271659Not applicable
- Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studYCompletedNCT02269982
- A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion CohortsActive, not recruitingNCT02266745Phase 2
- Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate CancerStatus unknownNCT02265159Phase 2/3
- Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate CarcinomaCompletedNCT02264379
- Study of ES414 in Metastatic Castration-Resistant Prostate CancerCompletedNCT02262910Phase 1
- Interest of Indocyanine Green in Neoplastic Prostatic TissueWithdrawnNCT02260349Phase 3
- Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated ScheduleCompletedNCT02257827Phase 3
- Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife DeviceActive, not recruitingNCT02255890
- Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate CancerStatus unknownNCT02254785Phase 2
- Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate BiopsyWithdrawnNCT02252978Phase 2
- Energy Balance for Prostate Cancer SurvivorshipCompletedNCT02252484Not applicable
- PASCUAL (Prostate Assay Specific Clinical Utility at Launch) StudyTerminatedNCT02250313
- The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate CancerCompletedNCT02250014Phase 1
- An Exercise Intervention for Prostate Cancer Patients Receiving Androgen Deprivation TherapyCompletedNCT02248350Not applicable
- Contrast Enhanced MRI of the ProstateCompletedNCT02245282
- Phase II Laser Focal Therapy of Prostate CancerActive, not recruitingNCT02243033
- MRI and Biomarkers in Prostate CancerCompletedNCT02241122Not applicable
- Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate CancerCompletedNCT02238366
- Diffusion-Weighted MRI in Staging Patients With Localized Prostate CancerCompletedNCT02237612Not applicable
- Immune Monitoring on Sipuleucel-TCompletedNCT02237170
- A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical CareCompletedNCT02236637
- Prostatic Cancer Versus Androgen DeficiencyCompletedNCT02235142Not applicable
- Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.CompletedNCT02234089
- MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound GuidanceStatus unknownNCT02233725Phase 1
- Advanced Pelvic Floor Training Program for Prostate Cancer SurgeryCompletedNCT02233608Phase 1/2
- Choline PET/CT vs. Dual Time Point FDG PET/CT in Prostate CancerCompletedNCT02232724Not applicable
- Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate CancerCompletedNCT02232685Not applicable
- Choline PET/CT vs. MeAIB PET/CT in Prostate CancerWithdrawnNCT02232672Not applicable
- A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-TCompletedNCT02232230
- Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)CompletedNCT02230059
- Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2CompletedNCT02229734Phase 2
- Molecular Mechanisms Underlying Prostate Cancer DisparitiesCompletedNCT02229565
- Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate CancerCompletedNCT02229253
- Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving EnzalutamideCompletedNCT02228265
- Radium-223 in Combination With EnzalutamideCompletedNCT02225704Phase 2
- A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate TumorsStatus unknownNCT02225262Not applicable
- A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate CancerCompletedNCT02225093Phase 1
- Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate CancerCompletedNCT02224911
- Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation TherapyCompletedNCT02220829Phase 3
- Randomized Study Comparing MR-guided in Bore Versus MRI/US Fusion-guided Prostate BiopsyCompletedNCT02220517Not applicable
- Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal DoseCompletedNCT02212548Not applicable
- Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer PatientsCompletedNCT02209584
- Molecular Phenotype Changes and Personalized Treatment for CRPCStatus unknownNCT02208583Not applicable
- Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate CancerCompletedNCT02207504Phase 1
- Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate CancerWithdrawnNCT02206724Not applicable
- Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerCompletedNCT02206334Phase 1
- Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate CancerCompletedNCT02204943Early Phase 1
- Phase 1 of EC1169 In Patients With Recurrent MCRPCCompletedNCT02202447Phase 1
- MR-guided Focal Laser Ablation of the ProstateCompletedNCT02200809Not applicable
- Evaluation of Lithium and It's Effect on Clinically Localized Prostate CancerCompletedNCT02198859Phase 1
- Phase III Radium 223 mCRPC-PEACE IIIActive, not recruitingNCT02194842Phase 3
- Phase II Study of SBRT as Treatment for Oligometastases in Prostate CancerCompletedNCT02192788Not applicable
- Prostate Cancer Upgrading Reference SetCompletedNCT02189486
- Navigator Guided e-Psychoeducational InterventionCompletedNCT02186444
- DEPORRA-CoProst: Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral ResectionsTerminatedNCT02185170Not applicable
- Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic CancerCompletedNCT02184533Phase 1
- LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After DocetaxelWithdrawnNCT02182622Phase 1
- Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate CancerCompletedNCT02182219Phase 1
- A Study With BIBF 1120 in Patients With Hormone Refractory Prostate CancerCompletedNCT02182063Phase 2
- Point in Time of Radiotherapy for Patients With Biochemical Recurrent Prostate CarcinomaStatus unknownNCT02181192Not applicable
- Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate CancerWithdrawnNCT02179762Not applicable
- Imaging of High Grade Prostate CancerTerminatedNCT02177526Not applicable
- High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)Active, not recruitingNCT02177292Not applicable
- Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate CancerActive, not recruitingNCT02176902Not applicable
- Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-IrradiationCompletedNCT02170181
- Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate CancerWithdrawnNCT02169063Not applicable
- Hyaluronic Acid for Hypofractionated Prostate RadiotherapyStatus unknownNCT02165020Phase 2
- Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate CancerCompletedNCT02163317Not applicable
- Detection of Lymphnodes Using ICG During RARPCompletedNCT02163083Not applicable
- A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate CancerCompletedNCT02162836Phase 1
- A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomyWithdrawnNCT02159690Phase 2
- Impact of a Printed Decision Aid on Patients' Intent to Undertake Prostate Cancer ScreeningCompletedNCT02156869Not applicable
- Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate CancerCompletedNCT02156414
- Non-Interventional Study PREVENTCompletedNCT02155998
- Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate CancerCompletedNCT02151760Phase 1
- PRIME - PRostate Imaging for Margin EvaluationCompletedNCT02151097
- The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric OxideCompletedNCT02149628Phase 4